Figures & data
Figure 1 A flowchart outlining the criteria for patient eligibility.
Table 1 Summary of Clinicopathological Features of ASPS in the Female Genital Tract at Our Institution
Figure 2 Histological findings and the results of special staining and immunostaining in case 3 are as follows: The tumor cells exhibit an organoid pattern (A) or a nest-like arrangement (B), with delicate fibrovascular septa separating them. PAS staining reveals the presence of purplish-red crystals in the cytoplasm (indicated by the yellow arrow) (C). Immunostaining shows diffuse positivity for TFE3 (D), while HMB-45 (E) and Melan-A (F) are negative. The original magnification for all images is 200×.
Figure 3 Fluorescence in situ hybridization demonstrates a break-apart signal indicating TFE3 rearrangement in case 3.
Figure 4 A diagrammatic representation is provided to illustrate the two variant gene fusions identified through targeted RNA sequencing analysis. The PRCC-TFE3 transcript consists of PRCC exon 7 fused to exons 2 of TFE3 in case 3.
Table 2 Summary of Clinicopathological Features of Previously Published Cases of ASPS in the Female Genital Tract
Table 3 Summary of Demographic and Treatment Information for ASPS Female Patients in the SEER Database
Table 4 Univariate and Multivariate Survival Analysis for ASPS Patients in the SEER Database